The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 Influenza Season
Open accessAbstract
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. ACIP makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. During the 2021-22 influenza season, the following types of vaccines are expected to be available: inactivated influenza vaccines (IIV4s), recombinant influenza vaccine (RIV4), and live attenuated influenza vaccine (LAIV4).The 2021-22 influenza season is expected to coincide with continued circulation of SARS-CoV-2, the virus that causes COVID-19. Influenza vaccination of persons aged ≥6 months to reduce prevalence of illness caused by influenza will reduce symptoms that might be confused with those of COVID-19. Prevention of and reduction in the severity of influenza illness and reduction of outpatient visits, hospitalizations, and intensive care unit admissions through influenza vaccination also could alleviate stress on the U.S. health care system. Guidance for vaccine planning during the pandemic is available at https://www.cdc.gov/vaccines/pandemic-guidance/index.html. Recommendations for the use of COVID-19 vaccines are available at https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/covid-19.html, and additional clinical guidance is available at https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html.Updates described in this report reflect discussions during public meetings of ACIP that were held on October 28, 2020; February 25, 2021; and June 24, 2021. Primary updates to this report include the following six items. First, all seasonal influenza vaccines available in the United States for the 2021-22 season are expected to be quadrivalent. Second, the composition of 2021-22 U.S. influenza vaccines includes updates to the influenza A(H1N1)pdm09 and influenza A(H3N2) components. U.S.-licensed influenza vaccines will contain hemagglutinin derived from an influenza A/Victoria/2570/2019 (H1N1)pdm09-like virus (for egg-based vaccines) or an influenza A/Wisconsin/588/2019 (H1N1)pdm09-like virus (for cell culture-based and recombinant vaccines), an influenza A/Cambodia/e0826360/2020 (H3N2)-like virus, an influenza B/Washington/02/2019 (Victoria lineage)-like virus, and an influenza B/Phuket/3073/2013 (Yamagata lineage)-like virus. Third, the approved age indication for the cell culture-based inactivated influenza vaccine, Flucelvax Quadrivalent (ccIIV4), has been expanded from ages ≥4 years to ages ≥2 years. Fourth, discussion of administration of influenza vaccines with other vaccines includes considerations for coadministration of influenza vaccines and COVID-19 vaccines. Providers should also consult current ACIP COVID-19 vaccine recommendations and CDC guidance concerning coadministration of these vaccines with influenza vaccines. Vaccines that are given at the same time should be administered in separate anatomic sites. Fifth, guidance concerning timing of influenza vaccination now states that vaccination soon after vaccine becomes available can be considered for pregnant women in the third trimester. As previously recommended, children who need 2 doses (children aged 6 months through 8 years who have never received influenza vaccine or who have not previously received a lifetime total of ≥2 doses) should receive their first dose as soon as possible after vaccine becomes available to allow the second dose (which must be administered ≥4 weeks later) to be received by the end of October. For nonpregnant adults, vaccination in July and August should be avoided unless there is concern that later vaccination might not be possible. Sixth, contraindications and precautions to the use of ccIIV4 and RIV4 have been modified, specifically with regard to persons with a history of severe allergic reaction (e.g., anaphylaxis) to an influenza vaccine. A history of a severe allergic reaction to a previous dose of any egg-based IIV, LAIV, or RIV of any valency is a precaution to use of ccIIV4. A history of a severe allergic reaction to a previous dose of any egg-based IIV, ccIIV, or LAIV of any valency is a precaution to use of RIV4. Use of ccIIV4 and RIV4 in such instances should occur in an inpatient or outpatient medical setting under supervision of a provider who can recognize and manage a severe allergic reaction; providers can also consider consulting with an allergist to help identify the vaccine component responsible for the reaction. For ccIIV4, history of a severe allergic reaction (e.g., anaphylaxis) to any ccIIV of any valency or any component of ccIIV4 is a contraindication to future use of ccIIV4. For RIV4, history of a se
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fiore, A. E., Uyeki, T. M., Broder, K. R., Finelli, L., Euler, G. L., Singleton, J. A., Iskander, J. K., Wortley, P. M., Shay, D. K., Bresee, J., et al. (2009) · PubMed · Cited by 2,077
Self-citationGrohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6703a1 · Cited by 1,632
Self-citation2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
Effectiveness of maternal influenza immunization in mothers and infants
Zaman, K., Roy, E., Arifeen, S. E., Rahman, M., Raqib, R., Wilson, E., Omer, S. B., Shahid, N. S., Breiman, R. F., & Steinhoff, M. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708630 · Cited by 1,227
Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States
Siston, A. M. (2010) · JAMA · doi:10.1001/jama.2010.479 · Cited by 1,034
(2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03793.x · Cited by 957
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
DiazGranados, C. A., Dunning, A. J., Kimmel, M., Kirby, D., Treanor, J., Collins, A., Pollak, R., Christoff, J., Earl, J., Landolfi, V., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315727 · Cited by 876
Self-citationThe Underrecognized Burden of Influenza in Young Children
Poehling, K. A., Edwards, K. M., Weinberg, G. A., Szilagyi, P., Staat, M. A., Iwane, M. K., Bridges, C. B., Grijalva, C. G., Zhu, Y., Bernstein, D. I., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054869 · Cited by 872
Shefer, A. M., & Atkinson, W. W. (2011) · Cited by 665
Influenza vaccination of pregnant women and protection of their infants
Madhi, S. A., Cutland, C. L., Kuwanda, L., Weinberg, A., Hugo, A., Jones, S., Adrian, P. V., van Niekerk, N., Treurnicht, F., Ortiz, J. R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401480 · Cited by 556
Pearson, M. L., Bridges, C. B., & Harper, S. A. (2006) · PsycEXTRA Dataset · doi:10.1037/e506932006-001 · Cited by 529
Patel, A., Jernigan, D. B., 2019-nCoV CDC Response Team, 2019-nCoV CDC Response Team, Abdirizak, F., Abedi, G., Aggarwal, S., Albina, D., Allen, E., Andersen, L., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6905e1 · Cited by 449
Self-citation(2011) · PubMed · Cited by 424
Falsey, A. R., Treanor, J. J., Tornieporth, N., Capellan, J., & Gorse, G. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/599790 · Cited by 388
IMPACT OF EPIDEMIC TYPE A INFLUENZA IN A DEFINED ADULT POPULATION
BARKER, W. H., & MULLOOLY, J. P. (1980) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113052 · Cited by 370
Grohskopf, L. A., Alyanak, E., Broder, K. R., Blanton, L. H., Fry, A. M., Jernigan, D. B., & Atmar, R. L. (2020) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6908a1 · Cited by 332
Self-citationRolfes, M. A., Foppa, I. M., Garg, S., Flannery, B., Brammer, L., Singleton, J. A., Burns, E., Jernigan, D., Olsen, S. J., Bresee, J., et al. (2018) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12486 · Cited by 310
Maternal Influenza Vaccination and Effect on Influenza Virus Infection in Young Infants
Eick, A. A., Uyeki, T. M., Klimov, A., Hall, H., Reid, R., Santosham, M., & O’Brien, K. L. (2011) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2010.192 · Cited by 302
Effects of Influenza Vaccination in the United States During the 2017–2018 Influenza Season
Rolfes, M. A., Flannery, B., Chung, J. R., O’Halloran, A., Garg, S., Belongia, E. A., Gaglani, M., Zimmerman, R. K., Jackson, M. L., Monto, A. S., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz075 · Cited by 297
Self-citationEfficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older
Dunkle, L. M., Izikson, R., Patriarca, P., Goldenthal, K. L., Muse, D., Callahan, J., & Cox, M. M. J. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608862 · Cited by 291
Barker, W. H. (1986) · American Journal of Public Health · doi:10.2105/ajph.76.7.761 · Cited by 290
Tapia, M. D., Sow, S. O., Tamboura, B., Tégueté, I., Pasetti, M. F., Kodio, M., Onwuchekwa, U., Tennant, S. M., Blackwelder, W. C., Coulibaly, F., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30054-8 · Cited by 245
Influenza- and RSV-associated hospitalizations among adults
Mullooly, J. P., Bridges, C. B., Thompson, W. W., Chen, J., Weintraub, E., Jackson, L. A., Black, S., & Shay, D. K. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.09.041 · Cited by 235
Steinhoff, M. C., Katz, J., Englund, J. A., Khatry, S. K., Shrestha, L., Kuypers, J., Stewart, L., Mullany, L. C., Chu, H. Y., LeClerq, S. C., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30252-9 · Cited by 227
Patel, A., & Jernigan, D. B. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15805 · Cited by 197
Kissling, E., Valenciano, M., Larrauri, A., Oroszi, B., Cohen, J. M., Nunes, B., Pitigoi, D., Rizzo, C., Rebolledo, J., Paradowska-Stankiewicz, I., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.05.20390-en · Cited by 195
Ferdinands, J. M., Fry, A. M., Reynolds, S., Petrie, J. G., Flannery, B., Jackson, M. L., & Belongia, E. A. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw816 · Cited by 195
Self-citationNeuzil, K. M., Jackson, L. A., Nelson, J., Klimov, A., Cox, N., Bridges, C. B., Dunn, J., DeStefano, F., & Shay, D. (2006) · The Journal of Infectious Diseases · doi:10.1086/507309 · Cited by 191
The Burden of Influenza in Young Children, 2004–2009
Poehling, K. A., Edwards, K. M., Griffin, M. R., Szilagyi, P. G., Staat, M. A., Iwane, M. K., Snively, B. M., Suerken, C. K., Hall, C. B., Weinberg, G. A., et al. (2013) · Pediatrics · doi:10.1542/peds.2012-1255 · Cited by 183
Ritzwoller, D. P., Bridges, C. B., Shetterly, S., Yamasaki, K., Kolczak, M., & France, E. K. (2005) · Pediatrics · doi:10.1542/peds.2005-0049 · Cited by 182
Izurieta, H. S., Thadani, N., Shay, D. K., Lu, Y., Maurer, A., Foppa, I. M., Franks, R., Pratt, D., Forshee, R. A., MaCurdy, T., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)71087-4 · Cited by 181
Gravenstein, S., Davidson, H. E., Taljaard, M., Ogarek, J., Gozalo, P., Han, L., & Mor, V. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30235-7 · Cited by 176
Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern Italy
Mannino, S., Villa, M., Apolone, G., Weiss, N. S., Groth, N., Aquino, I., Boldori, L., Caramaschi, F., Gattinoni, A., Malchiodi, G., et al. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws313 · Cited by 171
Pebody, R. G., Andrews, N., McMenamin, J., Durnall, H., Ellis, J., Thompson, C. I., Robertson, C., Cottrell, S., Smyth, B., Zambon, M., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.05.20389-en · Cited by 163
Izurieta, H. S., Chillarige, Y., Kelman, J., Wei, Y., Lu, Y., Xu, W., Lu, M., Pratt, D., Chu, S., Wernecke, M., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy716 · Cited by 163
Castilla, J., Martínez‐Baz, I., Martínez-Artola, V., Reina, G., Pozo, F., Cenoz, M. G., Guevara, M., Moran, J., Irisarri, F., Arriazu, M., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.05.20388-en · Cited by 162
Van Buynder, P. G., Konrad, S., Van Buynder, J. L., Brodkin, E., Krajden, M., Ramler, G., & Bigham, M. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.059 · Cited by 160
Young, B. E., Sadarangani, S. P., Jiang, L., Wilder‐Smith, A., & Chen, M. I.-C. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix632 · Cited by 157
McMillan, M., Porritt, K. A., Kralik, D., Costi, L., & Marshall, H. S. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.02.068 · Cited by 155
Belongia, E. A., Sundaram, M. E., McClure, D. L., Meece, J. K., Ferdinands, J. M., & VanWormer, J. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.06.052 · Cited by 152
Self-citationLee, J. K. H., Lam, G., Shin, T., Kim, J., Krishnan, A., Greenberg, D. P., & Chit, A. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1471989 · Cited by 149
Frey, S. E., Reyes, M. R. A.-D. L., Reynales, H., Bermal, N., Nicolay, U., Narasimhan, V., Forleo‐Neto, E., & Arora, A. K. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.013 · Cited by 145
Kissling, E., Nunes, B., Robertson, C., Valenciano, M., Reuß, A., Larrauri, A., Cohen, J. M., Oroszi, B., Rizzo, C., Machado, A., et al. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.16.30201 · Cited by 145
Coleman, B. L., Fadel, S. A., Fitzpatrick, T., & Thomas, S.-M. (2017) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12504 · Cited by 145
Bratton, K. N., Wardle, M. T., Orenstein, W. A., & Omer, S. B. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu915 · Cited by 143
Patterson, J. L., Randle, S. C., Hageman, J. R., & Kelley, K. R. (2013) · Pediatric Annals · doi:10.3928/00904481-20131122-09 · Cited by 137
Influenza Virus Infection in Travelers to Tropical and Subtropical Countries
Mütsch, M., Tavernini, M., Marx, A., Gregory, V., Lin, Y. P., Hay, A. J., Tschopp, A., & Steffen, R. J. (2005) · Clinical Infectious Diseases · doi:10.1086/429243 · Cited by 136
Eisenberg, K. W., Szilagyi, P. G., Fairbrother, G., Griffin, M. R., Staat, M. A., Shone, L. P., Weinberg, G. A., Hall, C. B., Poehling, K. A., Edwards, K. M., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2007-3304 · Cited by 133
Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season
Allison, M. A., Daley, M. F., Crane, L. A., Barrow, J. C., Beaty, B. L., Allred, N. J., Berman, S., & Kempe, A. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.06.036 · Cited by 130
ACOG Committee Opinion No. 732: Influenza Vaccination During Pregnancy
(2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002588 · Cited by 127
Intraseason Waning of Influenza Vaccine Effectiveness
Ray, G. T., Lewis, N., Klein, N. P., Daley, M. F., Wang, S. V., Kulldorff, M., & FIREMAN, B. H. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy770 · Cited by 122
Pasternak, B., Svanström, H., Mølgaard‐Nielsen, D., Krause, T. G., Emborg, H., Melbye, M., & Hviid, A. P. (2012) · BMJ · doi:10.1136/bmj.e2794 · Cited by 121
Sukumaran, L., McCarthy, N. L., Kharbanda, E. O., Weintraub, E., Vazquez‐Benitez, G., McNeil, M. M., Li, R., Klein, N. P., Hambidge, S. J., Naleway, A. L., et al. (2015) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001066 · Cited by 117
Donahue, J. G., Kieke, B. A., King, J. P., Destefano, F. R., Mascola, M. A., Irving, S. A., Cheetham, T. C., Glanz, J. M., Jackson, L. A., Klein, N. P., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.06.069 · Cited by 112
Chambers, C., Johnson, D., Xu, R., Luo, Y. J., Louik, C., Mitchell, A. A., Schatz, M. X., & Jones, K. L. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.08.097 · Cited by 111
Shay, D. K., Chillarige, Y., Kelman, J. A., Forshee, R. A., Foppa, I., Wernecke, M., Lu, Y., Ferdinands, J. M., Iyengar, A., Fry, A. M., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw641 · Cited by 108
Self-citationSafety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study
Heikkinen, T., Young, J., van Beek, E., Franke, H. R., Verstraeten, T., Weil, J., & Cioppa, G. D. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.07.007 · Cited by 104
ACOG Committee Opinion No. 741: Maternal Immunization
(2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002662 · Cited by 103
Kerzner, B., Murray, A. V., Cheng, E., Ifle, R., Harvey, P. R., Tomlinson, M., Barben, J. L., Rarrick, K., Stek, J. E., Chung, M., et al. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01397.x · Cited by 96
Schwarz, T. F., Flamaing, J., Rümke, H. C., Pénzes, J., Juergens, C., Wenz, A., Jayawardene, D. A., Giardina, P. C., Emini, E. A., Gruber, W. C., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.031 · Cited by 94
Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018–2019
Izurieta, H. S., Chillarige, Y., Kelman, J. A., Wei, Y., Lu, Y., Xu, W., Lu, M., Pratt, D., Wernecke, M., MaCurdy, T. E., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa080 · Cited by 93
Izurieta, H. S., Lu, M., Kelman, J. A., Lu, Y., Lindaas, A., Loc, J., Pratt, D., Wei, Y., Chillarige, Y., Wernecke, M., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1727 · Cited by 92
Schwarz, T. F., Aggarwal, N., Moeckesch, B., Schenkenberger, I., Claeys, C., Douha, M., Godeaux, O., Grupping, K., Heineman, T. C., López‐Fauqued, M., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix481 · Cited by 89
Trivalent Inactivated Influenza Vaccine and Spontaneous Abortion
Irving, S. A., Kieke, B. A., Donahue, J. G., Mascola, M. A., Baggs, J. M., Destefano, F. R., Cheetham, T. C., Jackson, L. A., Naleway, A. L., Glanz, J. M., et al. (2013) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e318279f56f · Cited by 88
Febrile Seizure Risk After Vaccination in Children 6 to 23 Months
Duffy, J., Weintraub, E., Hambidge, S. J., Jackson, L. A., Kharbanda, E. O., Klein, N. P., Lee, G. M., Marcy, S. M., Nakasato, C. C., Naleway, A. L., et al. (2016) · PEDIATRICS · doi:10.1542/peds.2016-0320 · Cited by 88
A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy
Oppermann, M., Fritzsche, J., Weber‐Schoendorfer, C., Keller‐Stanislawski, B., Allignol, A., Meister, R., & Schaefer, C. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.081 · Cited by 84
Fragaszy, E., Warren‐Gash, C., White, P. J., Zambon, M. C. F. A., Edmunds, W. J., Nguyen‐Van‐Tam, J. S., Hayward, A. C., & on behalf of the Flu Watch Group (2017) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12506 · Cited by 83
Chang, L.-J., Meng, Y., Janosczyk, H., Landolfi, V. A., & Talbot, H. K. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.08.016 · Cited by 80
Self-citationLarge Summertime Influenza A Outbreak among Tourists in Alaska and the Yukon Territory
Uyeki, T. M., Zane, S. B., Bodnar, U. R., Fielding, K., Buxton, J. A., Miller, J. M., Beller, M. J., Butler, J. C., Fukuda, K., Maloney, S. A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374053 · Cited by 76
Chambers, C., Johnson, D. L., Xu, R., Luo, Y. J., Louik, C., Mitchell, A. A., Schatz, M. X., & Jones, K. L. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.06.054 · Cited by 76
Young‐Xu, Y., van Aalst, R., Mahmud, S. M., Rothman, K. J., Snider, J. T., Westreich, D. J., Mor, V., Gravenstein, S., Lee, J. K. H., Thommes, E. W., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy088 · Cited by 75
Frenck, R. W., Gurtman, A., Rubino, J., Smith, W., van Cleeff, M., Jayawardene, D. A., Giardina, P. C., Emini, E. A., Gruber, W. C., Scott, D. A., et al. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00176-12 · Cited by 73
Lum, L. C. S., Borja-Tabora, C., Breiman, R. F., Vesikari, T., Sablan, B. P., Chay, O. M., Tantracheewathorn, T., Schmitt, H.-J., Lau, Y., Bowonkiratikachorn, P., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.11.054 · Cited by 70
Richardson, D. M., Medvedeva, E. L., Roberts, C. B., & Linkin, D. R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ261 · Cited by 68
Ferdinands, J. M., Gaglani, M., Martin, E. T., Monto, A. S., Middleton, D. B., Silveira, F. P., Talbot, H. K., Zimmerman, R. K., & Patel, M. M. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab045 · Cited by 62
Self-citationWaning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015
Puig‐Barberà, J., Mira‐Iglesias, A., Tortajada‐Girbés, M., López‐Labrador, F. X., Librero, J., Díez‐Domingo, J., Carballido‐Fernández, M., Carratalá‐Munuera, C., Medina, P. C., Gil-Guillén, V. F., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.09.035 · Cited by 61
Donahue, J. G., Kieke, B. A., King, J. P., Mascola, M. A., Shimabukuro, T. T., DeStefano, F., Hanson, K. E., McClure, D. L., Olaiya, O., Glanz, J. M., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.09.035 · Cited by 59
The impact of influenza infection on young children, their family and the health care system
Willis, G. A., Preen, D. B., Richmond, P., Jacoby, P. A., Effler, P. V., Smith, D. W., Robins, C., Borland, M. L., Levy, A., Keil, A. D., et al. (2018) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12604 · Cited by 59
Stockwell, M. S., Broder, K. R., LaRussa, P. S., Lewis, P., Fernandez, N., Sharma, D., Barrett, A. E., Sosa, J., & Vellozzi, C. J. (2014) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2013.4469 · Cited by 57
Self-citationRadin, J. M., Hawksworth, A. W., Myers, C. A., Ricketts, M. N., Hansen, E. A., & Brice, G. T. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.05.034 · Cited by 55
Ferdinands, J. M., Alyanak, E., Reed, C., & Fry, A. M. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz452 · Cited by 55
Self-citationInfluenza and Workplace Productivity Loss in Working Adults
Wormer, J. J. V., King, J. P., Gajewski, A., McLean, H. Q., & Belongia, E. A. (2017) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001120 · Cited by 54
Sammon, C., Snowball, J. M., McGrogan, A., & de Vries, C. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051734 · Cited by 52
Beran, J., Reynales, H., Põder, A., Yu, C. Y., Pitisuttithum, P., Yuan, L. L., Vermeulen, W., Verhoeven, C., Leav, B. A., Zhang, B., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30694-0 · Cited by 50
Nolan, T. M., Bernstein, D. I., Block, S. L., Hilty, M. D., KEYSERLING, H. L., Marchant, C. D., Marshall, H. S., Richmond, P., Yogev, R., Cordova, J. M., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2007-1064 · Cited by 49
Lapi, F., Marconi, E., Simonetti, M., Baldo, V., Rossi, A., Sessa, A., & Cricelli, C. A. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1622418 · Cited by 49
Millman, A. J., Duong, K. K., Lafond, K. E., Green, N. M., Lippold, S. A., & Jhung, M. A. (2015) · Journal of Travel Medicine · doi:10.1111/jtm.12215 · Cited by 47
Li, R., Stewart, B., McNeil, M. M., Duffy, J., Nelson, J. C., Kawai, A. T., Baxter, R. P., Belongia, E. A., & Weintraub, E. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3996 · Cited by 45
Essink, B. J., Fierro, C. A., Rosen, J., Figueroa, A. L., Zhang, B., Verhoeven, C., Edelman, J. M., & Smolenov, I. V. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.10.021 · Cited by 44
Ratnam, I., Black, J., Leder, K. S., Biggs, B., Gordon, I., Matchett, E., Padiglione, A. A., Woolley, I. J., Karapanagiotidis, T., Gherardin, T., et al. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.01.008 · Cited by 40
Song, J. Y., Cheong, H. J., Tsai, T. F., Chang, H.-A., Choi, M. J., Jeon, J. H., Kang, S. H., Jeong, E. J., Noh, J. Y., & Kim, W. J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.05.003 · Cited by 34
McNeil, S., Noya, F., Dionne, M., Predy, G., Meekison, W., Ojah, C., Ferro, S., Mills, E. L., Langley, J. M., & Halperin, S. A. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.12.047 · Cited by 31
Huang, W., Tang, F.-W., Yang, S.-E., Chih, Y.-C., & Chuang, J.-H. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.09.054 · Cited by 31
Schmader, K. E., Liu, C., Harrington, T. A., Rountree, W., Auerbach, H., Walter, E. B., Barnett, E. D., Schlaudecker, E. P., Todd, C. A., Poniewierski, M. S., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.31266 · Cited by 28
Self-citationLevin, M. J., Buchwald, U. K., Gardner, J. E., Martin, J. C., Stek, J. E., Brown, E., & Popmihajlov, Z. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.08.029 · Cited by 27
Prospective Cohort Study of the Safety of an Influenza A(H1N1) Vaccine in Pregnant Chinese Women
Ma, F., Zhang, L., Jiang, R., Zhang, J., Wang, H., Gao, X., Li, X., & Liu, Y. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00375-14 · Cited by 24
Influenza vaccine failure in the tropics: a retrospective cohort study of waning effectiveness
Young, B. E., Mak, T. M., Ang, L. W., Sadarangani, S. P., Ho, H. J. A., Wilder‐Smith, A., Barkham, T., & Chen, M. (2020) · Epidemiology and Infection · doi:10.1017/s0950268820002952 · Cited by 21
Nakashima, K., Aoshima, M., Ohfuji, S., Yamawaki, S., Nemoto, M., Hasegawa, S., Noma, S., Misawa, M., Hosokawa, N., Yaegashi, M., et al. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1455476 · Cited by 20
Fever After Influenza, Diphtheria-Tetanus-Acellular Pertussis, and Pneumococcal Vaccinations
Walter, E. B., Klein, N. P., Wodi, A. P., Rountree, W., Todd, C. A., Wiesner, A., Duffy, J., Marquez, P., & Broder, K. R. (2020) · PEDIATRICS · doi:10.1542/peds.2019-1909 · Cited by 19
Self-citationNg, Y., Nandar, K., Chua, L. A. V., Mak, T. M., Foo, K., Muhammad, I. R., Low, C. K. K., Ma, S., Ooi, S. P. L., Lin, R. T. P., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.03.054 · Cited by 15
Mira‐Iglesias, A., López‐Labrador, F. X., García‐Rubio, J., Mengual‐Chuliá, B., Tortajada‐Girbés, M., Mollar‐Maseres, J., Carballido‐Fernández, M., Schwarz‐Chavarri, G., Puig‐Barberà, J., & Díez‐Domingo, J. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031129 · Cited by 11
Cited by
Uyeki, T. M., Hui, D. S., Zambon, M., Wentworth, D. E., & Monto, A. S. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00982-5 · Cited by 560
Grohskopf, L. A., Blanton, L. H., Ferdinands, J. M., Chung, J. R., Broder, K. R., Talbot, H. K., Morgan, R. L., & Fry, A. M. (2022) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7101a1 · Cited by 320
Self-citationSeasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe
Wiemken, T. L., Khan, F., Puzniak, L., Yang, W., Simmering, J., Polgreen, P., Nguyen, J. L., Jodar, L., & McLaughlin, J. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-31057-1 · Cited by 138
Handelsman, Y., Anderson, J. E., Bakris, G. L., Ballantyne, C. M., Beckman, J. A., Bhatt, D. L., Bloomgarden, Z. T., Bozkurt, B., Budoff, M. J., Butler, J., et al. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108101 · Cited by 64
Metadata
- Authors
- Grohskopf, L. A., Alyanak, E., Ferdinands, J. M., Broder, K. R., Blanton, L. H., Talbot, H. K., & Fry, A. M.
- Venue
- MMWR. Recommendations and Reports
- Published
- 2021-08-27
- Volume
- 70
- Issue
- 5
- Pages
- 1-28
- ISSN
- 1057-5987 (ISSN-L)
- 1545-8601
- OpenAlex
- W4206441133
- Cited by
- 360
- References
- 101
- FWCI
- 43.05
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.